HealthExec November 23, 2021
Amy Baxter

Margin pressures among U.S. healthcare and pharmaceutical companies are at risk with renewed labor challenges and supply chain issues.

Healthcare companies are facing higher costs and potentially lost revenue as a result of these disruptions, according to a recent report from Fitch Ratings. However, healthcare companies are unlikely to suffer in the markets due to a temporary decline in profitability at the end of 2021.

Healthcare providers have been facing a shortage of workers for several months, which is causing many to raise wages and leverage more temporary health, which can also cost more. At the same time, retaining workers is also more challenging due to the effects of burnout and high rates of turnover. In particular, senior housing, skilled...

Today's Sponsors

Patient Bond
pCare
Institute for Healthcare Improvement

Today's Sponsors

Oliver Wyman
Patient Bond

Today's Sponsor

Patient Bond

 
Topics: Health System / Hospital, Provider, Supply Chain, Survey / Study, Technology, Trends
Mass General dinged for spending growth by state regulator
AHA asks for $25 billion as HHS releases $2 billion in provider relief funds
COVID Risk In Hospitals.
Improving self-reported empathy and communication skills through harm in healthcare response training.
JPM 40th Annual Healthcare Conference: Familiar Themes with a Confident Tone